Biomarkers solution


Artialis provides in its portfolio exclusive biomarkers to assess musculoskeletal diseases. These biomarkers are endpoints used in preclinical studies and clinical trials to assess the efficacy of a tested product. Moreover, Artialis has set up a complete procedure of external kits selection and validation allowing to propose in studies and testing service the higher level of quality. Finally, Artialis has the capability to design and develop specific on-demand biomarkers supporting each step of your product development.

Artialis soluble biomarkers
 © Artialis - All rights reserved
Terms & conditions - Privacy Policy